Cargando…
Reduced pro-inflammatory dendritic cell phenotypes are a potential indicator of successful peanut oral immunotherapy
Dendritic cells are important mediators in the early presentation of antigen and regulation of the differentiation of T cells. Peanut oral immunotherapy (POIT) results in desensitization in most peanut allergic individuals (responders), but not in others due to allergic reactions (non-responders). D...
Autores principales: | Anvari, Sara, Watkin, Levi B., Minard, Charles G., Schuster, Kimberly, Hassan, Oluwatomi, Anagnostou, Aikaterini, Orange, Jordan S., Corry, David B., Davis, Carla M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135258/ https://www.ncbi.nlm.nih.gov/pubmed/35617270 http://dx.doi.org/10.1371/journal.pone.0264674 |
Ejemplares similares
-
Peanut immunotherapy
por: Anagnostou, Katherine, et al.
Publicado: (2014) -
A Practical, Stepwise Approach to Peanut Oral Immunotherapy in Clinical Practice: Benefits and Risks
por: Anagnostou, Aikaterini
Publicado: (2021) -
Oral immunotherapy for peanut allergy: The pro argument
por: Chinthrajah, R. Sharon, et al.
Publicado: (2020) -
Identification of goals and barriers to treatment from 92 consecutive consultations with families considering peanut oral immunotherapy
por: Blackman, Andrea C., et al.
Publicado: (2019) -
Children and caregiver proxy quality of life from peanut oral immunotherapy trials
por: Galvin, Audrey Dunn, et al.
Publicado: (2022)